For CFOs, healthcare administrators, practice executives, and other financial decision-makers, revenue cycle performance is about much more than whether last month’s dashboard was green or red.
The real question is: What are your revenue cycle numbers telling you about the money your organization has earned, the money it is likely to collect, and the money it may be leaving on the table?
As you prepare for 2027, reviewing revenue cycle KPIs should go beyond reporting totals and trends. Leadership needs to understand what is driving those numbers, where financial leakage is occurring, and whether the underlying operational problems are getting better or simply moving from one report to another.
A strong revenue cycle analysis should help answer questions like these.
1. How much of your A/R still represents a realistic cash opportunity?
Total A/R and days in A/R are important, but they do not tell the whole story.
Leadership should know how much of the organization’s A/R has moved beyond 90 and 120 days, what percentage remains realistically collectible, and why those balances are aging.
Is the problem concentrated with certain Payors? Are claims being denied? Are there registration or eligibility issues? Are authorizations missing? Is documentation holding up payment? Or is follow-up simply not happening quickly enough?
Two organizations can have the same days in A/R and very different financial situations.
That is why A/R should be evaluated based on collectibility, age, source, and cause, not simply the total balance.
The goal is to identify the portion of A/R that represents a realistic future cash opportunity versus balances that are becoming increasingly difficult to recover.
2. Are contractual adjustments actually contractual?
A large adjustment total can look perfectly normal on a financial statement. But what is hiding inside those adjustments?
CFOs should be reviewing adjustment activity by payor, reason code, provider, and service line to determine whether write-offs are truly supported by contractual obligations.
Unexpected adjustment activity can reveal:
- Incorrect fee schedules
- Underpayments
- Inappropriate write-offs
- Posting errors
- Incorrect contractual calculations
- Reimbursement discrepancies
- Problems with Payor configuration
If an organization is routinely writing off revenue that should have been collected, the issue is not simply an accounting entry. It is a revenue problem.
A billing integrity audit can help identify inappropriate adjustments, underpayments, coding issues, and other sources of lost reimbursement.
This is why adjustment analysis should be connected to reimbursement expectations and contractual terms.
3. Are we being paid according to our Payor contracts?
A payment posting report can tell you what was paid.
It cannot, by itself, tell you whether you were paid what you should have been paid.
Leadership should have a process for comparing expected reimbursement against actual reimbursement and identifying Payor-specific variances. Legacy’s reimbursement analysis compares actual payments against contracted rates to identify underpayments and missed reimbursement opportunities.
That analysis can uncover patterns that organization-wide collection metrics may completely miss.
For example, a Payor may appear to be performing reasonably based on overall collections while consistently underpaying certain procedures, providers, locations, or service lines.
Contractual reimbursement should not be treated as a static document that lives in a file cabinet. It should be connected to actual payment performance. That is where regular payor contract review and analysis becomes important.
If expected reimbursement and actual reimbursement are not being compared, leadership may not know how much revenue is being lost through underpayments.
4. What percentage of denials represents preventable operational failure?
An overall denial rate is useful, but it is not enough to drive meaningful improvement.
Leadership needs to know why claims are being denied and whether those causes are preventable.
Denials should be analyzed by categories such as eligibility, authorization, registration, coding, documentation, timely filing, medical necessity, Payor configuration, and other operational causes.
More importantly, those categories should be monitored for recurring patterns.
If the same authorization issue appears every month, the organization does not have a denial problem. It has a workflow problem that is producing denials.
That distinction matters.
The financial goal is not simply to work denials faster. It is to reduce the number of preventable denials entering the revenue cycle in the first place.
5. How much revenue has been earned but has not yet reached the Payor?
One of the easiest ways to misunderstand revenue cycle performance is to look only at A/R.
Revenue can be financially at risk before it ever becomes A/R.
Consider charge lag, encounters that have not been closed, claims sitting in work queues, rejected claims that have not reached the Payor, or services that were never submitted for billing.
That revenue may not appear in a traditional A/R report, but it still represents earned revenue that has not moved toward cash.
Leadership should understand how much revenue is sitting in this pre-billing stage and how quickly it is moving through the system.
A healthy-looking A/R report does not necessarily mean the revenue cycle is healthy.
6. Is cash performance changing because of volume, reimbursement, or revenue-cycle execution?
When collections decrease, the first question should not automatically be, “What went wrong with billing?”
Leadership needs to separate the impact of patient volume, Payor mix, reimbursement, claim submission performance, denials, and collection effectiveness.
For example, lower collections may be explained by lower patient volume. Or the organization could have stable volume but declining reimbursement. Or collections may be falling because claims are taking longer to submit and resolve.
Those are very different problems requiring very different solutions.
Without this level of analysis, organizations can spend money correcting the wrong issue.
The objective is to understand what is actually driving the change in cash performance.
7. Which Payors are creating the greatest financial drag?
Organization-wide averages can hide significant Payor-level problems.
Leadership should be able to compare Payors based on factors such as:
- Days to payment
- Denial frequency
- Underpayment patterns
- A/R aging
- Reimbursement performance
- Administrative burden
- Follow-up requirements
A Payor that consistently requires more staff time, produces more denials, pays more slowly, and reimburses below expectations may be creating a much greater financial drag than an organization-wide dashboard suggests.
Payor performance should therefore be viewed not only through the lens of collection percentage, but also through financial impact and operational effort.
8. What does patient A/R tell us about our front-end processes?
Growing patient A/R is often treated as a collections problem.
Sometimes, it is a front-end problem.
Patient balances can increase because of eligibility issues, inaccurate benefit estimates, high-deductible plan exposure, failure to collect at the point of service, or ineffective communication with patients about their financial responsibility.
That means patient A/R can provide valuable information about what is happening much earlier in the revenue cycle.
If patient balances are consistently growing, leadership should ask whether the organization is doing everything it can to establish accurate expectations and collect appropriately before and at the time of service.
9. Are revenue-cycle staffing costs producing the expected financial result?
For organizations with internal billing teams, payroll is only one part of the equation.
Leadership should evaluate staffing costs alongside productivity, claim volume, outstanding work queues, A/R aging, denial follow-up, and collections.
A team may appear fully staffed while critical work queues continue to grow. Conversely, an organization may be carrying unnecessary labor costs because workflows are inefficient or too much manual work is being performed.
The question is not simply, “How much are we spending on revenue-cycle staff?”
It is:
What financial result are we getting from that investment?
That requires connecting staffing resources to measurable revenue-cycle outcomes.
10. Where should leadership invest in 2027?
Ultimately, the purpose of reviewing revenue cycle KPIs is not to create a prettier dashboard.
It is to make better financial decisions.
Your analysis should help leadership determine where investment will have the greatest impact.
That could mean investing in technology. It could mean redesigning workflows, strengthening front-end processes, improving staff training, addressing Payor contracting issues, preventing denials, adding internal resources, or bringing in outside revenue cycle expertise.
The answer will be different for every organization.
The important thing is to make the decision based on evidence rather than assumptions.
Your 2027 Revenue Cycle Review Should Connect the Number to the Cause
Revenue cycle reporting is only valuable when it leads to action.
A dashboard can tell you that A/R is increasing. It cannot fix the reason why.
A denial report can tell you that denials are high. It cannot determine whether the root problem is authorization, registration, coding, documentation, or another operational breakdown unless someone analyzes the data.
A payment report can show what a Payor paid. It does not tell you whether that payment matches the reimbursement your organization was contractually entitled to receive.
That is where meaningful revenue cycle analysis begins.
The goal is not simply to know what happened. It is to understand why it happened and what needs to change.
As you prepare your 2027 budget, your revenue cycle deserves the same level of financial scrutiny as any other major area of the organization.
At Legacy Consulting Services, we help healthcare organizations look beyond the surface-level metrics to identify financial leakage, workflow gaps, Payor issues, and opportunities for improvement throughout the revenue cycle.
We do not simply process claims or produce reports. We help leadership understand what is happening to its revenue, why it is happening, and what operational changes can improve financial performance.
Is Your Revenue Cycle Ready for 2027?
Before you finalize next year’s budget, consider whether you can confidently answer these questions:
How much revenue has been earned but not yet billed?
How much revenue has been billed but is unlikely to be collected?
How much revenue has been collected below the amount contractually expected?
Those three numbers can reveal a very different picture of financial performance than a traditional KPI dashboard.
A 2027 Revenue Cycle Readiness Assessment can help identify where that gap exists and what should be addressed before the new year.
Legacy can evaluate the revenue cycle from patient access through final payment, helping leadership identify financial leakage, workflow weaknesses, Payor issues, and opportunities to improve revenue performance.
Because knowing your numbers is important.
Knowing what they mean, and what to do about them, is where the real value is.